good time to buy, page-86

I think a more conservative estimate would be a 25% increase on $40.7 = $50.8million.

Infant formula sales last year, 35,580 mt last year. top end of projection this year is 45,000 mt. Thats roughly a 25 percent increase.

By that logic full year profit should be around $93 million. For a company growing at 25% per year, I think the forward PE should be around 25.

This values the company at 2.3bn ~ a 15% upside to current share price.

Having said that, I think it is very likely that we will an upgrade to total infant formula sales. They already had inventory on hand of 26.7mt. This was built up in anticipation of increased demand for infant formula in FY19. The inventory is almost 60% of the top end of expected sales guidance. My guess is that management expect more growth than 45mt sales for FY19 but gave a conservative figure because it doesnt make sense to build up that much inventory when they only needed 10mt of inventory (plus 35mt of production) to meet the 45mt forecast.